Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,440 | -16,504 | -10,610 | -5,183 | -22,414 |
| Depreciation Amortization | 1,990 | 1,407 | 929 | 455 | 1,301 |
| Accounts receivable | -1,224 | -1,724 | -1,062 | -1,642 | 636 |
| Accounts payable and accrued liabilities | N/A | N/A | 296 | N/A | N/A |
| Other Working Capital | 71,091 | -1,612 | -663 | -1,992 | 2,050 |
| Other Operating Activity | 4,035 | 3,767 | 1,855 | 2,380 | 2,412 |
| Operating Cash Flow | $44,452 | $-14,666 | $-9,255 | $-5,982 | $-16,015 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -175 |
| PPE Investments | -6,122 | -5,573 | -4,153 | -1,244 | -3,370 |
| Other Investing Activity | -52 | -60 | -39 | -20 | -156 |
| Investing Cash Flow | $-6,174 | $-5,633 | $-4,192 | $-1,264 | $-3,701 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 293 | 200 | 8 | N/A | -51 |
| Financing Cash Flow | $293 | $200 | $8 | $N/A | $-51 |
| Exchange Rate Effect | 99 | 113 | -25 | -439 | 550 |
| Beginning Cash Position | 42,596 | 42,596 | 42,596 | 42,596 | 61,813 |
| End Cash Position | 81,266 | 22,610 | 29,132 | 34,911 | 42,596 |
| Net Cash Flow | $38,670 | $-19,986 | $-13,464 | $-7,685 | $-19,217 |
| Free Cash Flow | |||||
| Operating Cash Flow | 44,452 | -14,666 | -9,255 | -5,982 | -16,015 |
| Capital Expenditure | -6,195 | -5,648 | -4,226 | -1,305 | -3,371 |
| Free Cash Flow | 38,257 | -20,314 | -13,481 | -7,287 | -19,386 |